What is NERV's dilution risk score?

NERV has a latest available DilutionScore record of 42/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for NERV, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for NERV?

DilutionWatch tracks 25 SEC filing types for NERV including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect NERV shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For NERV, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for NERV tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for NERV. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

NERV Dilution Risk Score: 42/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

90

💰 Cash Runway

0

📊 Float Risk

25

⚠️ Warrant Exposure

40

🔄 Convertible Debt

15

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 10%

💰 Capital Raise model 20%

• Active shelf registration ($200M, 87% of market cap)

🔔 Track NERV — Get forecast alerts →

Market Data

Market Cap$228.75M

Shares Outstanding47.75M

Float30.87M

Cash$75.27M

Debt$9.39M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 115.3% shares (2026Q1 vs prior)

44 institutional holders · 49.67M shares

#1 Vivo Capital, LLC 8.65M shares

#2 JANUS HENDERSON GROUP PLC 8.59M shares

#3 FEDERATED HERMES, INC. 5.11M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.45M

Days to Cover15.5

% of Float7.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2025-12-31

4 INSIDER TRANSACTION 2026-06-05

Full SEC filing analysis available with free account →

Recent News

Minerva Neurosciences to Participate in Two Upcoming Investor Conferences GlobeNewswire · Aug 28

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Developme GlobeNewswire · Jun 01

All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy Yahoo Finance · May 20

Factual NERV Dilution Snapshot

Minerva Neurosciences, Inc. (NERV) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $200.0M.
Recent SEC activity tracked for NERV: 4 on 2026-06-05; 4 on 2026-06-05; 4 on 2026-06-05.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.